CANCER OF THE PROSTATE
Clinical trials for CANCER OF THE PROSTATE explained in plain language.
Never miss a new study
Get alerted when new CANCER OF THE PROSTATE trials appear
Sign up with your email to follow new studies for CANCER OF THE PROSTATE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Major trial tests new hope to keep prostate cancer at bay
Disease control CompletedThis large, completed Phase 3 trial tested whether the drug enzalutamide could safely delay the spread of cancer in men with a specific, hard-to-treat form of prostate cancer. Over 1,400 men whose cancer had stopped responding to standard hormone therapy but had not yet spread we…
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE3 • Sponsor: Pfizer • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Radioactive drug trial offers new hope for men with Tough-to-Treat prostate cancer
Disease control CompletedThis study tested whether adding a radioactive drug (I-131-1095) to standard medication (enzalutamide) could better control advanced prostate cancer that had worsened on a prior drug (abiraterone). It involved 120 men whose cancer had spread and was visible on a special PSMA scan…
Matched conditions: CANCER OF THE PROSTATE
Phase: PHASE2 • Sponsor: Progenics Pharmaceuticals, Inc. • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Researchers track how long men stay on prostate cancer drugs
Knowledge-focused CompletedThis study looked back at real-world medical records to understand how long men with advanced prostate cancer that still responds to hormone therapy actually stay on two common medications: apalutamide and enzalutamide. Researchers analyzed data from about 1,300 men who were trea…
Matched conditions: CANCER OF THE PROSTATE
Sponsor: Pfizer • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC